First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management Journavx is the first drug to be approved in this new class ...

Dr. Roger Hollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in developing gene replacement therapies using blood stem ...

South Texas Blood and Tissue Center (STBT), a subsidiary of San Antonio-based non-profit BioBridge Global and a recognized leader in prehospital transfusion. STBT has made history as the first U.S.

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Scientists have enabled a paralyzed man to control a drone using brain-computer interface technology, paving the way for ...

TANKER Foundation celebrated its 32nd Annual Charity and Awards Nite on Monday, 27th January 2025 at 5.30 pm at Hotel Savera, RK Salai, Chennai ...

Discover Qartemi, India's innovative CAR-T cell therapy for B-cell Non-Hodgkin Lymphoma, offering personalized and affordable ...

Learn about the harmful chemicals in common beauty products, their risks to kidney health, and safe, effective alternatives ...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III clinical trial of sparsentan for the ...

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

Every year, countless boys and young men fall victim to sex trafficking—a tragic crisis that remains overlooked in many anti-trafficking efforts.

Strategic media healthcare agency CMI Media Group, a WPP company (NYSE: WPP), has released a report offering new insights into how healthcare brands can support patients with obesity ...